Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Dan Streja, MD

Clinical Professor of Medicine
University of California, Los Angeles
Member of the Healthcare Council

Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has expertise in the management of diabetes, hypertension, hyperlipidemia, and antithrombotic therapy. He is a consultant in Endocrinology for a large managed care medical group. Dr. Streja also serves as the Medical Director of Infosphere Clinical Research. Previously, he was a Professor of Physiology at the University of Manitoba and specialized in the biochemistry of lipids and carbohydrate metabolism. Dr. Streja is a consultant for Abbott, BMS, Bayer, Eli-Lilly, Merck, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Pfizer, Roche, and Sankyo. (This is me - Update Profile)


Employment History
1979 - present Consultant Endocrinologist
Affiliates In Medical Specialties Medical Group, Inc
1979 - present Clinical Professor of Medicine
University of California, Los Angeles
1979 - present Co-director
VA MEDICAL CENTER

GLG NewsSM Analyses by Dan Streja, MD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Outsourcing of compassionate use of drugs? | 01-18-2008
Author: Dan Streja, MD, Clinical Professor of Medicine, University of California, Los Angeles

The Supreme Court has rejected the use of experimental drugs by the dying patients on the grounds that "The framers (of the US constitution) understood that the pursuit of life is an inalienable right that should not be abridged without due process of law." Over the years our patients with terminal...

GLG InstituteSM Seminars with Dan Streja, MD(?)

 
Dan Streja, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Dan Streja, MD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-08-29T09:45:18.400